Identification of inflamed aortic plaque in conventional fluorodeoxyglucose-positron emission tomography myocardial

Yingwei Liu1, Nina Ghosh, Girish Dwivedi

  • 1Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Abstract

Insights

Routine cardiac (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) scans can detect inflamed aortic plaque in patients with severe coronary artery disease. This feasibility study shows uptake in 77% of patients, with aggressive risk factor modification potentially lowering high uptake rates.

Area of Science:

  • Cardiovascular Imaging
  • Nuclear Medicine
  • Atherosclerosis Research

Background:

  • (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is established for identifying arterial inflammation.
  • Cardiac FDG-PET viability studies are routinely performed in patients with severe coronary artery disease and left ventricular dysfunction.

Purpose of the Study:

  • To evaluate the feasibility of detecting inflamed atherosclerotic plaque in the aorta using standard cardiac FDG-PET viability scans.
  • To assess FDG uptake in the thoracic aorta in patients undergoing myocardial viability assessment.

Main Methods:

  • Retrospective analysis of 103 clinically indicated myocardial viability scans (FDG-PET/CT).
  • FDG uptake in the thoracic aorta was quantified using target-to-background ratio (TBR).
  • Aortic uptake was graded based on peak and mean TBR values.

Main Results:

  • 77% of patients (79/103) showed increased FDG uptake in the aorta (mean TBR grade 1-3).
  • 12% of patients (12/103) exhibited grade 3 aortic uptake based on peak TBR.
  • The study population had a high prevalence of cardiovascular risk factors and treatments (e.g., statins, ACE inhibitors).

Conclusions:

  • Conventional FDG viability scans are feasible for detecting inflamed atherosclerotic plaque in the aorta.
  • The observed low rate of very high aortic FDG uptake may be attributed to effective secondary risk factor management.
  • These findings suggest a potential role for routine cardiac PET scans in assessing aortic inflammation in specific patient cohorts.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...